Security Snapshot

GLOBUS MEDICAL INC - Common Stock (GMED) Institutional Ownership

CUSIP: 379577208

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

481

Shares (Excl. Options)

79.62MFull value: 79,616,343 · shares · 30 Sep 2026

Price

$74.90

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.01%
Share change
+3,543,629
Value change
+$255,183,042
Number of holders
481
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
134,556,795
SEC-reported price per share
$81.41
Insider filing price
$81.41
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • GMED - GLOBUS MEDICAL INC - Common Stock is tracked under CUSIP 379577208.
  • 481 institutions reported positions in Q3 2026.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 601 to 481 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $9.43BFull value: $9,427,196,699 · USD · 30 Jun 2026
    to
    $5.96BFull value: $5,960,440,587 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 481 institutions filings for Q3 2026.

Open SEC evidence

Security key

379577208

13F reference period

Q3 2026

13F holders

481

13D/G owners

3

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
GMED
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 8% -12% $801,750,797 +$16,256,745 10,704,283 +2.1% BlackRock, Inc. 30 Sep 2026
JANUS HENDERSON GROUP PLC 6.1% +5% $522,135,958 +$30,787,723 7,029,294 +6.3% JANUS HENDERSON GROUP PLC 31 Mar 2025
VANGUARD CAPITAL MANAGEMENT LLC 4.4% $446,468,863 5,960,866 Vanguard Capital Management 30 Sep 2026
As of 30 Sep 2026, 481 institutional investors reported holding
79.62MFull value: 79,616,343 · shares · 30 Sep 2026
shares of GLOBUS MEDICAL INC - Common Stock (GMED). This represents 59% of the company’s total
134.56MFull value: 134,556,795 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
39%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Janus Henderson Group Ltd. 6.4% 8,634,195 0.27% $646,722,089
VANGUARD CAPITAL MANAGEMENT LLC 3.8% 5,075,559 0.01% $380,159,369
VANGUARD PORTFOLIO MANAGEMENT LLC 3.6% 4,866,366 0.02% $364,490,813
STATE STREET CORP 2.8% 3,718,553 0.01% $278,519,620
DIMENSIONAL FUND ADVISORS LP 2.2% 3,007,442 0.04% $225,264,959
Swedbank AB 2.1% 2,880,843 0.18% $215,775,142
ALLIANCEBERNSTEIN L.P. 2.1% 2,773,750 0.06% $207,753,920
Invesco Ltd. 1.9% 2,600,716 0.02% $194,793,628
GEODE CAPITAL MANAGEMENT, LLC 1.6% 2,132,827 0.01% $159,787,719
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 1.1% 1,447,365 0.35% $108,407,639
Quantinno Capital Management LP 1.1% 1,436,468 0.1% $107,591,491
MANUFACTURERS LIFE INSURANCE COMPANY, THE 0.96% 1,288,590 0.08% $96,515,391
GENEVA CAPITAL MANAGEMENT LLC 0.93% 1,249,396 2.6% $93,579,735
FULLER & THALER ASSET MANAGEMENT, INC. 0.9% 1,210,097 0.27% $90,636,286
Clark Capital Management Group, Inc. 0.88% 1,177,836 0.53% $88,219,916
BANK OF AMERICA CORP /DE/ 0.81% 1,087,018 0.01% $81,417,648
Madison Avenue Partners, LP 0.7% 936,540 2.8% $70,146,846
PARADIGM CAPITAL MANAGEMENT INC/NY 0.7% 935,499 2.2% $70,068,875
ANTIPODES PARTNERS Ltd 0.69% 931,430 1.3% $69,764,107
Vestal Point Capital, LP 0.68% 915,000 1.8% $68,533,500
GOLDMAN SACHS GROUP INC 0.58% 778,977 0.01% $58,345,385
Stephens Investment Management Group LLC 0.55% 734,180 0.59% $54,990,082
VANGUARD FIDUCIARY TRUST CO 0.53% 710,228 0.01% $53,196,077
ENVESTNET ASSET MANAGEMENT INC 0.52% 701,504 0.01% $52,542,650
ANCHOR CAPITAL ADVISORS LLC 0.47% 629,155 1.5% $47,123,677

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q3 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 79,616,343 $5,960,440,587 +$255,183,042 $74.90 481
2026 Q2 118,965,815 $9,427,196,699 +$674,113,955 $79.01 601
2026 Q1 109,497,605 $9,427,656,832 -$146,523,397 $86.16 609
2025 Q4 111,087,339 $9,706,953,561 +$150,539,278 $87.31 560
2025 Q3 115,933,964 $6,654,707,679 +$72,456,317 $57.27 488
2025 Q2 114,075,801 $6,730,550,265 +$195,769,879 $59.02 477
2025 Q1 109,345,858 $7,997,914,722 -$8,993,495 $73.20 507
2024 Q4 108,904,887 $9,007,980,911 +$44,310,752 $82.71 495
2024 Q3 108,072,594 $7,734,964,942 -$332,078,125 $71.54 444
2024 Q2 112,764,178 $7,722,959,830 -$3,143,182 $68.49 443
2024 Q1 113,402,229 $6,082,679,016 +$359,376,321 $53.64 435
2023 Q4 106,692,854 $5,685,431,048 -$155,605,070 $53.29 405
2023 Q3 109,414,808 $5,433,176,387 +$1,362,204,600 $49.65 426
2023 Q2 81,374,906 $4,843,899,307 +$408,515,363 $59.54 378
2023 Q1 74,600,238 $4,224,726,594 -$151,471,403 $56.64 381
2022 Q4 75,948,098 $5,639,196,814 +$86,702,611 $74.27 383
2022 Q3 74,451,382 $4,436,437,568 +$100,448,577 $59.57 356
2022 Q2 72,222,203 $4,054,750,490 +$112,004,727 $56.14 349
2022 Q1 69,530,797 $5,130,106,470 +$81,009,114 $73.78 366
2021 Q4 68,345,177 $4,935,105,853 +$7,508,095 $72.20 367
2021 Q3 67,700,811 $5,190,187,299 -$70,035,321 $76.62 380
2021 Q2 68,045,932 $5,276,020,366 +$27,082,820 $77.53 351
2021 Q1 67,739,467 $4,178,223,997 +$52,788,626 $61.67 338
2020 Q4 66,616,139 $4,344,582,646 +$137,526,882 $65.22 343
2020 Q3 64,418,606 $3,189,910,125 -$115,537,152 $49.52 336
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .